Jopromiidi hankimine

Järvamaa Haigla otsib 24-kuuliseks tarneks 623 mg/ml 200 ml Jopromiid süste-/infusioonilahust, kus kohustuslik on esitada täidetud “Riigihankes osalemise avaldus” ja “Tehniline kirjeldus/pakkumuse vorm” kooskõlas hanke alusdokumentidega, kinnitada pakkumuse vastavust kõigile tingimustele (sh samaväärsuse tõendamine), ning maksumus tuleb esitada ainult etteantud struktuuris – tingimuslikke pakkumusi ei aktsepteerita.

This is merely the bidder’s declaration form for the 24-month Jopromiidi (pharmaceutical) supply tender by Järvamaa Haigla, so it contains no product specs, qualification thresholds or award criteria—only the mandatory statement that the bidder accepts all (unspecified) terms in the full procurement file.

This is a straightforward 24-month public procurement by Järvamaa Hospital for two pack-sizes of the contrast agent Iopromide (200 ml & 500 ml bottles, 623 mg/ml) where bidders simply quote a unit price ex-VAT and no special qualifications or evaluation criteria are stated.

This is a pure price-based procurement where Järvamaa Hospital will award the 24-month supply contract for Jopromiid injection/infusion solutions (623 mg/ml, 200 ml and 500 ml) to the bidder offering the lowest total price, with no technical or qualification requirements beyond the ability to deliver the exact product listed.

This is only the ESPD template for a 24-month Jopromiidi (medicine) supply tender by Järvamaa Haigla; it lists no mandatory quantities, technical specs, delivery terms or financial/qualification thresholds—merely the empty fields the bidder will later have to complete online—so companies cannot yet decide whether to bid.

AS Järvamaa Haigla seeks a 24-month supply of the drug Jopromiid (CPV “Ravimid”) delivered free to its Paide pharmacy within 3 working days of order; bidders must quote a fixed final price (VAT extra), guarantee quality, accept quantity variations and price-reduction clauses, issue e-invoices referencing the tender, and replace or compensate for any non-conforming goods—no special licences or experience thresholds are stated, so any pharmaceutical wholesaler able to stock and promptly deliver this medicine should consider bidding.